Larvol Delta - A-Trial-of-ONO4578-Versus-Placebo-in-Combination-With-Nivolumab-and-Chemotherapy-in-Participants-With-Gastric-Cancer-Esophagogastric-Junction-Cancer-or-Esophageal-Adenocarcinoma

2141-V11 - Memorial Sloan-Kettering Cancer Center, Rockefeller University

5-fluorouracil - Generic mfg.

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

http://clinicaltrials.gov/ct2/show/NCT07818018

Sep 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next